Tuesday, January 27, 2026 8:35:28 AM
GNTA.........................................https://stockcharts.com/sc3/ui/?s=GNTA&p=w&b=5&g=0&id=p86431144783
Recent GNTA News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 08:05:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/01/2026 08:05:19 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/27/2026 10:10:25 AM
- Genenta, evolving into Saentra Forge, has signed a Binding Offer with Sòphia High Tech, an Italian company manufacturing critical parts for Europe's space and defense programs • GlobeNewswire Inc. • 03/27/2026 09:00:00 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/25/2026 08:39:04 PM
- Genenta Science evaluates biotech partnerships as it shifts strategic focus • IH Market News • 03/24/2026 10:41:04 AM
- Genenta, evolving into Saentra Forge, continues to evaluate strategic options for its original biotechnology platform derived from the research of Professor Luigi Naldini • GlobeNewswire Inc. • 03/24/2026 07:26:56 AM
- Genenta, Evolving into Saentra Forge, Announces CEO’s Appointment by the Italian Government to the Board of Guarantors of the Italian Academy at Columbia University • GlobeNewswire Inc. • 03/13/2026 09:00:00 AM
- Genenta Advances Transformation into Saentra Forge, Strengthens ATC Governance and Expands Strategic Industrial Consolidation Platform • GlobeNewswire Inc. • 02/27/2026 09:00:00 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 01/27/2026 11:10:58 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/27/2026 11:05:38 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/27/2026 11:03:51 AM
- Genenta Announces Strategic Transformation into a Biotech, Defense, Aerospace, and National Security Industrial Consolidator • GlobeNewswire Inc. • 01/27/2026 08:00:00 AM
- Genenta Science Provides Update on CEO Ownership • GlobeNewswire Inc. • 12/19/2025 07:30:00 AM
- Genenta Reports Long-Term Survival Trends and Immune Findings in Brain Tumor (GBM) Trial • GlobeNewswire Inc. • 11/24/2025 09:00:00 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 10/28/2025 05:20:21 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/28/2025 10:17:01 AM
- Genenta Science stock tumbles as $15 million ADS sale sparks dilution worries • IH Market News • 10/27/2025 04:11:08 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/27/2025 10:03:52 AM
- Genenta Announces Pricing of $15.0 Million Registered Direct Offering of American Depositary Shares • GlobeNewswire Inc. • 10/27/2025 12:30:00 AM
- Genenta and Anemocyte Announce Strategic Partnership to Advance Off-The-Shelf LVV Plasmid DNA Production • GlobeNewswire Inc. • 10/24/2025 08:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/10/2025 08:06:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/03/2025 08:05:22 PM
